Overview
Ambeon Capital is a diversified investment holding company with clusters in IT services (MillenniumIT ESP), financial services (Sherwood Capital, Ambeon Securities, Taprobane Investments/Taprobane Capital Plus), real estate and strategic investments, and a centralised group treasury. It also holds a 22.1% associate stake in Dankotuwa Porcelain and has pursued export-aligned projects.
The key current development is a proposed capital raise via a rights issue and private placement, intended to de-lever the balance sheet and fund new equity investments. Against this, the most recent quarter moved further into a net loss, with finance costs and other below-the-line items absorbing operating gains.
Price performance
At LKR 30.40 as of 2026-08-06, TAP has underperformed the market in recent months: -15.5% over three months versus the ASPI’s -6.5%, and -31.9% over six months versus -11.3%. The one-year return remains positive at 17.2% against the ASPI’s 9.3%.
The share sits 36.1% below its 52-week high and 17.2% above its low, around the 21% mark of its range. Recent volatility has eased versus its own year (-24.9% on a 60-day basis), while 20-day volume is 37.6% above the 60-day average.
Valuation
TAP trades on 12.35x trailing earnings and 3.59x book, versus sector medians of 7.43x and 1.0x. By our sector percentiles it is expensive on P/B (98th) and P/E (75th). FY25 ROE was 16.3%, which only partly reconciles the premium multiple set.
The dividend yield is 6.6% on a trailing DPS of LKR 2.00, implying an 81% payout and 1.23x cover. The dataset does not provide a multi-year dividend history here to judge payout direction.
News and sentiment
Coverage has been unusually heavy: 5 articles in the last 30 days versus a 2.3 monthly baseline. Over the past 90 days we count 7 material items, split 3 positive, 4 neutral, 0 negative.
The company announced a 1:10 rights issue at LKR 32 and a contingent private placement, together targeting up to LKR 4.0 billion, subject to approvals. Trading was briefly halted pending disclosures and resumed on 20 July. Group-related disclosures also included a mandatory offer process at Harischandra Mills via Ambeon Essentials.
Financials
For the quarter to 2026-03-31, revenue rose 24.0% year-on-year to LKR 6.98 billion. Gross margin was 22.6% (vs 25.8% a year ago), while operating margin improved 1.1 points to 4.6%, lifting operating profit to LKR 320 million.
Below the line remained heavy: the below-the-line drag was LKR 675 million, including LKR 385 million of finance costs. Net margin was -5.1% (vs -5.5% a year ago) for a net loss of LKR 355 million, and the database characterises this as a loss that widened by LKR 47 million.
On ranks against its own March quarters, gross margin was among its worst (6 of 7), operating margin among its best (2 of 4), and net margin middling (5 of 7). Equity attributable to owners stood at LKR 8.65 billion. The share count increased from 1.003 billion at 2025-12-31 to 1.022 billion at 2026-03-31, so per-share moves over that span reflect issuance as well as performance.
For FY2025, operating margin was 7.3% and net margin 9.2%, with ROE at 16.3%. Full-year net profit fell 32.7% year-on-year. As at 2026-08-07, the next filing for the 2026-06-30 period is due, so these figures are about to be superseded.
Risks
Balance sheet leverage is the primary risk: gearing measured at 171.6% of owners’ equity (FY25), with interest cover only 1.73x. This leaves results sensitive to funding costs, as seen in the latest quarter’s LKR 385 million finance charge.
Valuation leaves little room for missteps, with P/B at 3.59 versus a sector median 1.0. Minority interests are material, with 34.5% of group net profit attributable to non-controlling interests in FY25, so group earnings are not fully available to TAP shareholders. The stock is higher beta (1.51), implying larger swings relative to the ASPI.
Outlook
Two near-term catalysts frame the next leg. First, the 2026-06-30 results are due now (exchange window runs to 2026-10-26) and will show whether the operating improvement seen quarter-on-quarter is holding while the below-the-line drag eases. Second, the rights and private placement are announced but not yet dated; as at 7 August 2026 the estimated ex window runs between 11 August and 2 November, and securing approvals and terms will determine how quickly leverage can be reduced.
As at 7 August 2026, T-bill yields had been easing, consistent with potential relief to finance costs if maintained; how much of that flows through is the key sensitivity to watch alongside equity raise progress.